首页> 外国专利> NEW USE OF NCS-1 (NEURON SPECIFIC CALCIUM SENSOR-1) FOR THE TREATMENT OF CNS DISORDERS AND THE DEVELOPMENT OF THERAPEUTIC AGENTS

NEW USE OF NCS-1 (NEURON SPECIFIC CALCIUM SENSOR-1) FOR THE TREATMENT OF CNS DISORDERS AND THE DEVELOPMENT OF THERAPEUTIC AGENTS

机译:NCS-1(神经元特异性钙传感器-1)在中枢神经系统疾病治疗和治疗剂开发中的新用途

摘要

Provided is a method for determining whether an agent is an agonist of the neuron-specific calcium sensor-1 (NCS-1), for consideration of an agonist of NCS-1 as a drug candidate for therapy of a behavioral disorder or for improving learning and/or memory of a subject, said method comprising the steps of: (a) contacting a cell, tissue or non-human animal with an agent to be screened under conditions to permit neuron-specific calcium sensor-1 (NCS-1) activity; and (b) determining NCS-1 activity of said treated cell, tissue or non-human animal, wherein an increase in NCS-1 activity compared with a corresponding control cell, tissue or animal is indicative of an agent which is an agonist of NCS-1.
机译:提供了一种用于确定药剂是否为神经元特异性钙传感器1(NCS-1)的激动剂,考虑将NCS-1的激动剂用作治疗行为障碍或改善学习的药物的方法和/或受试者的记忆,所述方法包括以下步骤:(a)在允许神经元特异性钙传感器1(NCS-1)的条件下,使细胞,组织或非人类动物与待筛选的试剂接触。活动; (b)确定所述处理过的细胞,组织或非人类动物的NCS-1活性,其中与相应的对照细胞,组织或动物相比,NCS-1活性的增加表明该试剂是NCS的激动剂-1。

著录项

  • 公开/公告号FR2824478B1

    专利类型

  • 公开/公告日2007-09-21

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号FR20020004797

  • 发明设计人 PATRICK NEF;

    申请日2002-04-17

  • 分类号A61K38/17;A61K48/00;A61K39/395;A61P25/00;C12Q1/68;C12Q1/02;A01K67/027;G01N33/68;C12N15/12;

  • 国家 FR

  • 入库时间 2022-08-21 20:27:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号